RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Financials
  4. FCF margin (%)

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$364.6M
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 2024-4,199.1-49.98%
Dec 31, 2018-8,394.7-22.73%
Dec 31, 2017-10,864+11.70%
Dec 31, 2016-9,725.7+98.14%
Dec 31, 2015-4,908.5+397.45%
Dec 31, 2013-986.7+25.33%
Dec 31, 2012-787.3+10.10%
Dec 31, 2011-715.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)